temozolomide has been researched along with Cancer of Mediastinum in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors retrospectively evaluated 3 patients with progressive, metastatic neuroendocrine tumors of the thymus who were treated with a combination of capecitabine and temozolomide." | 7.79 | Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series. ( Centeno, B; Kvols, L; Morse, B; Saranga-Perry, V; Strosberg, J, 2013) |
| "The authors retrospectively evaluated 3 patients with progressive, metastatic neuroendocrine tumors of the thymus who were treated with a combination of capecitabine and temozolomide." | 3.79 | Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series. ( Centeno, B; Kvols, L; Morse, B; Saranga-Perry, V; Strosberg, J, 2013) |
| "Temozolomide was given orally at 150 mg/m2/day on days 1-5." | 2.71 | Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors. ( Bacik, J; Bajorin, D; Bosl, GJ; Marion, S; Mazumdar, M; Motzer, RJ; Schwartz, L; Sheinfeld, J; Varuni Kondagunta, G; Vuky, J, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maroto, P | 1 |
| Huddart, R | 1 |
| Garcia del Muro, X | 1 |
| Horwich, A | 1 |
| Paz Ares, L | 1 |
| Aparicio, J | 1 |
| Germa-Lluch, JR | 1 |
| Saranga-Perry, V | 1 |
| Morse, B | 1 |
| Centeno, B | 1 |
| Kvols, L | 1 |
| Strosberg, J | 1 |
| Varuni Kondagunta, G | 1 |
| Bacik, J | 1 |
| Schwartz, L | 1 |
| Sheinfeld, J | 1 |
| Bajorin, D | 1 |
| Vuky, J | 1 |
| Marion, S | 1 |
| Mazumdar, M | 1 |
| Bosl, GJ | 1 |
| Motzer, RJ | 1 |
2 trials available for temozolomide and Cancer of Mediastinum
| Article | Year |
|---|---|
Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumors.
Topics: Adult; Antineoplastic Agents; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Humans; Male; Media | 2011 |
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors.
Topics: Adult; Cisplatin; Confidence Intervals; Dacarbazine; Drug Resistance, Neoplasm; Female; Germinoma; H | 2004 |
1 other study available for temozolomide and Cancer of Mediastinum
| Article | Year |
|---|---|
Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Flu | 2013 |